![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 7, 5222-5227, February 18, 2000
From the Cancer Research Center, The Burnham Institute,
La Jolla, California 92037
R-Ras contains a proline-rich motif that
resembles SH3 domain-binding sites but that has escaped notice
previously. We show here that this site in R-Ras is capable of binding
SH3 domains and that the SH3 domain binding may be important for R-Ras
function. A fusion protein containing the SH3 domains of the adaptor
protein Nck interacted strongly with the R-Ras proline-rich sequence
and with the intact protein. The binding was independent of whether R-Ras was in its GDP or GTP form. The Nck binding, which was mediated by the second of the three SH3 domains of Nck, was obliterated by
mutations in the proline-rich sequence of R-Ras. The interaction of Nck
with R-Ras could also be shown in yeast two-hybrid assays and by
co-immunoprecipitation in human cells transfected with Nck and R-Ras.
Previous results have shown that the expression of a constitutively
active R-Ras mutant, R-Ras(38V), converts mouse 32D monocytic cells
into highly adherent cells. Introducing the proline mutations into
R-Ras(38V) suppressed the effect of R-Ras on 32D cell adhesion while
not affecting GTP binding. These results reveal an unexpected
regulatory pathway that controls R-Ras through an SH3 domain
interaction. This pathway appears to be important for the ability of
R-Ras to control cell adhesion.
Integrins mediate cell adhesion to extracellular matrices and, in
some cases, to other cells. Their activity also helps regulate cell
survival, growth, differentiation, and migration. Integrin activity is,
in turn, regulated by the cell. The most striking examples of regulated
integrin activity are the activation of the platelet
The molecular mechanisms of integrin regulation are not well
understood. There appear to be two ways of enhancing the cell attachment-promoting activity of integrins; clustering of integrins at
the cell surface can enhance the avidity of integrins in cell attachment, whereas conformational changes can increase the affinity of
individual integrin molecules (3-6). Cytoskeletal connections of
integrins are likely to be important in the avidity regulation (7),
whereas the affinity of integrins may be regulated by other types of
proteins. Cytohesins are phosphatidylinositol-binding proteins, at
least one of which binds to the cytoplasmic tail of the
Certain oncoproteins can change integrin activity, generally by
lowering it. Thus, c-Src phosphorylates a tyrosine residue in the
R-Ras, a small GTPase with a poorly understood function, regulates
integrin activity (17-21). Unlike Ras, R-Ras promotes integrin activity and converts cells that normally grow in suspension into highly adhesive cells (17). Moreover, a dominant negative R-Ras (R-Ras(43N)), when transfected into adherent cells, causes the cells to
round up, suggesting that R-Ras is necessary for the maintenance of
integrin activity (17). Unlike dominant negative mutants of the
oncogenic Ras proteins, R-Ras(43N) is not growth inhibitory (20). Thus,
R-Ras may be primarily a regulator of cell adhesion, and it is
important to understand how this regulation functions.
Examining R-Ras for sequence features that might be responsible for its
integrin activating function, we noticed that R-Ras differs from Ras
and most other members of Ras superfamily small GTPases in that it
possesses a distinct proline-rich site. We show here that this site can
bind SH3 domains and that the adaptor protein Nck is one of the SH3
domain proteins that interact with R-Ras in cells. We also show that
the SH3-binding site is required for integrin activating function of
R-Ras. These results reveal an unexpected regulatory interaction for
R-Ras that appears to be important for the ability of R-Ras to control
cell adhesion. This interaction represents a novel form of cross-talk
between a small GTPase and other cellular signaling pathways.
Cells, Antibodies, and Reagents--
Mouse monocytic cell line
32D.3 was maintained essentially as described (17) in RPMI 1640 medium
supplemented with 1 mM glutamine, 100 units/ml penicillin
G, 100 µg/ml streptomycin, 10% heat-inactivated fetal calf serum,
and 20% conditioned medium from the interleukin-3-producing cell line
WEHI-3B. Human embryonic kidney 293 cells were maintained in
Dulbecco's modified Eagle's medium plus 10% fetal calf serum.
Polyclonal rabbit antibody against the N-terminal 26-amino acid peptide
of R-Ras was a gift from Dr. John Reed (21). Mouse monoclonal antibody
against hemagglutinin (HA)1
12CA5 was provided by Dr. J.-L. Guan. Mouse hybridoma cell line producing monoclonal antibody 9E10 against Myc epitope was obtained from American Type Cell Culture. Polyclonal anti-Nck antibody was
purchased from Santa Cruz Biotechnology. Human plasma fibronectin was
from the Finnish Red Cross.
Plasmid Construction and Recombinant Protein
Purification--
To create the maltose-binding protein (MBP) fusion
plasmid pMBP-RRC, two oligonucleotides spanning the coding
sequence for amino acids 191-212 (RKYQEQELPPSPPSAPRKKGGG) of
R-Ras were synthesized with XbaI and EcoRI
overhangs (sense strand:
5'-ATTCAGGAAATACCAGGAACAAGAGCTCCCACCGAGCCCTCCCAGTGCCCCCAGGAAGAAGGCCGGGGGCTAGT-3' (underlined letters indicate codons for prolines 202 and 203); antisense strand:
5'-CTAGACTAGCCCCCGCCCTTCTTCCTGGGGGCACTGGGAGGGCTCGGTGGGAGCTCTTGTTCCTGGTATTTCCTG-3'). The oligonucleotides were annealed, phosphorylated by using
polynucleotide kinases, and ligated in frame into the pPR997 maltose
fusion protein vector (New England Biolab) digested with
XbaI and EcoRI. Mutants were derived by changing
the codon for proline to alanine at amino acids 202 (P202A), 203 (P203A), or both 202 and 203 (P202A,P203A). The plasmids were
transformed into Escherichia coli strain XL-1 blue
(Strategene), and MBP fusion proteins were purified according the
manufacturer's instructions.
To introduce double proline to alanine (P202A,P203A) mutations into the
R-Ras mammalian expression vector, R-Ras was first amplified by
polymerase chain reaction using a 3' antisense primer containing
P202A,P203A mutations
(5'-GCTCTAGACTCGAGCTACAGGAGGACGCAGGGGCAGCCCCCGCCCTTCTTCCTGGGGGCACTGGGAGGGCTGGCGGCGAGCTCTTGTTC-3', underlining indicates P202A,P203A mutations) and a 5' primer at the
beginning of R-Ras coding sequence (5'-ATGAGCTCTGGTGCT-3'). The
polymerase chain reaction product was digested with XbaI and StuI, which cuts near nucleotides coding for amino acid 174 of R-Ras. This fragment was then cloned into pcDNA3-HA-R-Ras(wt) or
pcDNA3-HA-R-Ras(38V) to obtain pHRR(wt)-(P202A,P203A) and
pHRR(38V)-(P202A,P203A) respectively. The same fragment was also cloned
into pcDNA3-Myc-R-Ras (pMRR) to create pMRR-(P202A,P203A). All
constructs were verified by dideoxynucletotide sequencing (U. S.
Biochemical Corp.). pEBB-Nck was a generous gift from Dr. B. Mayer
(22).
Preparation of glutathione S-transferase (GST) fusion
proteins with SH3 domains from Src and Crk (N) (23), p85 In Vitro Binding of MBP-R-Ras Fusion Proteins to GST-SH3 Fusion
Proteins--
About 10 µg of MBP alone, MBP-RRC, or its mutants were
labeled with Na125I using Iodogen (Pierce) as described
previously (29). In a typical binding assay, 10 µg of a GST-SH3
domain fusion proteins in phosphate-buffered saline (PBS) was
immobilized on glutathione-Sepharose. The beads were washed twice with
PBS and once with the binding buffer (25 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.5% Nonidet P-40,
0.05% SDS, 1% BSA, and 0.2 mM phenylmethylsulfonyl
fluoride, and resuspended in 20 µl of the same buffer at 4 °C.
About 1 × 106 cpm of 125I-labeled MBP-RRC
fusion protein in PBS containing 1% BSA was added to each tube and
incubated for 30 min at 4 °C. The beads were washed four times with
binding buffer without BSA. The bound materials were eluted with 50 µl of SDS-polyacrylamide gel electrophoresis (PAGE) loading buffer,
separated on 4-20% gradient SDS-PAGE minigel (Novex, San Diego), and
exposed to x-ray films.
In Vitro Binding Assays with GTP-bound and GDP-bound Forms of
R-Ras--
A GST-R-Ras fusion protein containing the entire R-Ras
protein was immobilized on glutathione-Sepharose beads. The beads were washed with loading buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 5 mM EDTA, and 0.1% BSA) and split
into two tubes. The beads were incubated with 1 mM GTP Yeast Two-hybrid Assay--
The yeast two-hybrid system was used
to study protein-protein interactions essentially as described (30,
31). A cDNA encoding R-Ras without CAAX box (the
CAAX box was removed to allow nuclear localization of R-Ras)
was amplified with polymerase chain reaction and cloned into
EcoRI and SmaI sites of pBTM116, and the SH3
domains of Nck were cloned into the Klenow-treated BamHI and
NotI sites of VP16. As a negative control, lamin cDNA
was cloned into BTM116. Yeast strain L40 was co-transfected with 1 µg
of each plasmid by the LiCl method (32). One-tenth of the transformed
yeast cells were plated onto medium lacking uracil, tryptophan, and leucine (UTL) for analysis of transformation efficiency, and
nine-tenths were plated onto medium lacking tryptophan, histidine,
uracil, leucine, and lysine (THULL). UTL colonies were grown for 2 days at 30 °C and then restreaked onto UTL and THULL plates. Filters were
loaded on the plates with streaks from yeast transformation, frozen in
liquid nitrogen, and warmed to room temperature and then stained with
0.4 mg/ml 5-bromo-4chloro-3-indolyl- Transient Transfection, Immunoprecipitation, and Immunoblot
Analysis--
Human embryonic kidney 293 cells on 100-mm plates were
transiently transfected with 10 µg of the indicated vectors using
standard calcium phosphate precipitation method. Two days later, cells were lysed in buffer A containing 50 mM Tris-HCl, 50 mM NaCl, 0.5% Triton X-100, 10% glycerol, 0.1% BSA, and
protease inhibitors (0.1 unit/ml aprotinin, 10 µg/ml leupeptin, and
0.5 mM phenylmethylsulfonyl fluoride). Lysates were
clarified by centrifugation at 15,000 × g for 10 min.
Antibodies were added to lysates containing equal amount of proteins
and incubated for 1 h at 4 °C. To precipitate the
antibody-antigen complex, Gammabind Sepharose (Amersham Pharmacia Biotech) was added, and incubation was continued for another hour. The
immunoprecipitates, pelleted by centrifugation, were washed twice with
buffer A containing 0.1% BSA, and once with buffer A alone. The beads
were boiled in sample buffer and separated on SDS-PAGE gels. After
electrophoresis, proteins were transferred to Immobilon-P nylon
membrane (Millipore) and subjected to immunoblotting. Filters were
first blocked for 1 h with blocking buffer (3% milk plus 1% BSA
in PBS) and incubated with primary antibodies (1 µg/ml) for 1 h.
Horseradish peroxidase-conjugated secondary antibodies (Sigma) were
added at 1:5000 dilutions in blocking buffer. Membrane were developed
with Enhanced Luminol Reagents from DuPont.
Stable Transfection of 32D Cells--
Log phase 32D.3 cells were
transfected with indicated plasmids by as described (16). One day after
transfection, 0.7 µg/ml Geneticin (G418) (Life Technologies, Inc.)
was added. Individual clones were obtained by limited dilution. Level
of expression in each clone was examined by immunoblot with an anti-HA
epitope monoclonal antibody 12CA5.
Cell Adhesion Assay--
Serial dilutions of fibronectin in PBS
was coated on 96-well microtiter plates starting at 10 µg/ml.
Nonspecific binding sites were blocked with 1% BSA in PBS. 32D cells
and their transfectants were collected by pipetting or by using brief
treatment with 1 mM EDTA in PBS. The suspended cells were
washed and plated in duplicate onto fibronectin-coated wells in
serum-free medium at 1 × 105 cells/well and allowed
to adhere for 1 h at 37 °C. Adherent cells were fixed with
3.7% paraformaldehyde and stained with 0.5% crystal violet, which was
then extracted with 50% ethanol in 50 mM sodium citrate,
pH 4.5, and quantitated by measuring absorbance at 595 nm.
GTP Binding Assay--
10 µg of purified GST-R-Ras,
GST-R-Ras-(P202A,P203A) or GST were incubated with 10 µCi of
[ R-Ras Contains a Proline-rich Region That Resembles SH3
Domain-binding Sites--
In a search for potential mediators for the
integrin activating function of R-Ras, we examined sequence features of
R-Ras outside the effector domain. As shown in Fig.
1 a proline-rich region toward the C
terminus of R-Ras contains three possible PXXP minimal SH3
domain recognition sequences, one of which conforms to the consensus
features of a preferred binding site for type II SH3 domains (33, 34).
No PXXP motif is present in other members of Ras superfamily
small GTPases with the exception of TC21 and CDC42Hs. TC21 is most
closely related to R-Ras (35) and contains a single PPSP motif (Fig.
1B). CDC42Hs belongs to the Rho subfamily of small GTPases
(36), its PPEPKK site also conforms to the consensus type II
SH3-binding motif (Fig. 1B). Interestingly, the
brain-specific version of CDC42Hs, G25K, (37) lacks the potential
SH3-binding site.
Proline-rich Region of R-Ras Selectively Interacts with SH3 Domains
in Vitro--
To determine whether R-Ras can indeed bind to SH3
domain-containing proteins, we fused the C-terminal portion of R-Ras
(amino acids 192-212) to MBP and screened a panel of GST-SH3 domain
fusion proteins for binding to this fusion protein, MBP-RRC. A
recombinant protein encompassing the three SH3 domains of Nck bound
avidly to MBP-RRC (Fig. 2A).
By counting the excised band, it was estimated that about 12% of
125I-labeled MBP-RRC could be bound by the Nck SH3 domain
fragment. None of the other SH3 domains tested exhibited binding above
the background level of GST alone. As a control, MBP alone was tested and did not bind to any SH3 domain fusion proteins under the same conditions (Fig. 2A, lower panel). These results
show that the proline-rich domain of R-Ras can serve as selective
binding site for SH3 domain-containing proteins, Nck in particular.
SH3 Domain Binding Requires Proline Residues 202 and 203 of
R-Ras--
To demonstrate that the interaction between the C-terminal
portion of R-Ras and Nck is mediated by the proline-rich region, proline to alanine point mutations were introduced to alter the PXXP motifs in R-Ras. Fig. 2B shows that mutation
of proline 202 to alanine (P202A), which eliminates the first
PXXP site (Fig. 1A), greatly reduced the binding
to Nck SH3 domains. Disrupting the second and third PXXP
sites with the P203A mutation similarly reduced Nck binding. Mutating
both prolines (P202A,P203A) resulted in further reduction of the Nck
binding. These results show that the proline-rich domain is required
for binding to Nck SH3 domains. Testing with fusion proteins containing
various combinations of the three Nck SH3 domains showed that only the
middle SH3 domain of Nck binds R-Ras (Fig. 2C).
Nck SH3 Domain Fragment Binds to Both GTP-bound and GDP-bound R-Ras
in Vitro--
To investigate the role of GTP binding in the R-Ras
interaction with Nck, binding of Nck to GTP-bound and GDP-bound
R-Ras-GST fusion protein was examined. Nck was found to bind both the
GTP and GDP forms of R-Ras, indicating that the Nck interaction is not
regulated by the R-Ras nucleotide binding (Fig. 2D).
R-Ras Associates with Nck in Yeast Cells--
The interaction
between R-Ras and Nck in cells was examined initially in a yeast
two-hybrid assay (38, 39). A Nck fragment encoding the SH3 domains was
the "prey," and R-Ras with a deleted CAAX box
(R-Ras-CAAX R-Ras and Nck Form a Complex in Mammalian Cells--
To study
R-Ras-SH3 domain interaction in mammalian cells, we transiently
transfected Nck into 293 cells together with HA-tagged R-Ras or
R-Ras-(P202A,P203A). Immunoprecipitation and immunoblot shows that
wild-type R-Ras co-immunoprecipitated with Nck and that P202A,P203A
mutation significantly reduced that association (Fig.
4A, left half).
Similar results were obtained when cells were transfected with
HA-tagged Nck and Myc-tagged R-Ras or R-Ras-(P202A,P203A) (Fig.
4A right half). These results indicate that R-Ras and Nck can associate in intact cells and that proline-rich domain is necessary
for the association.
The Proline-rich Domain of R-Ras Is Required for Integrin
Regulation by R-Ras--
We have previously demonstrated that an
activated form of R-Ras, R-Ras(38V), can induce substrate attachment of
32D mouse monocytic cells, which normally grow in suspension, and that
the increased adhesiveness is caused by integrin activation (17). We
next used this assay to determine whether the proline-rich site
contributes to the integrin-regulating activity of R-Ras. A major
proportion of transfected 32D cells expressing the activated R-Ras(38V)
became adherent and spread on tissue culture dishes (Fig.
5A), whereas 32D cells
expressing an R-Ras(38V) mutated in the two SH3-binding domain proline
residues (R-Ras(38V)-(P202A,P203A)) grew in suspension (Fig.
5B). Control cells, including those transfected with vector
alone (Fig. 5C), parental cells (not shown), and
R-Ras(wt)-transfected cells (below), also remained nonadherent.
To quantitate the effects of the P202A,P203A mutation on
integrin-mediated cell adhesion, 32D transfectants were plated onto wells coated with varying concentrations of fibronectin.
R-Ras(38V)-transfected cells adhered to fibronectin, but clones
expressing the R-Ras(38V)-(P202A,P203A) mutant either did not adhere to
fibronectin or adhered poorly to it (Fig. 5D). That the
various transfectants expressed equivalent levels of the transfected
R-Ras was confirmed by immunoblotting cell extracts with anti-HA
antibody (not shown). No adhesion was observed with R-Ras(wt)- or
vector-transfected cells. Similar results were obtained when another
adhesive protein, vitronectin, was used to coat the substrate. The lack
of cell attachment-promoting activity by the R-Ras(38V)-(P202A,P203A)
mutant was unlikely to be due to a loss of GTP binding capability,
because controls showed the P202A,P203A mutation to have no effect on
GTP binding by R-Ras (Fig. 6). These
results indicate that the proline-rich domain contributes to the
integrin activating function of R-Ras, possibly by interacting with the
SH3 domains of Nck.
Our results reveal an unexpected regulatory interaction of R-Ras
that is mediated through binding to SH3 domains. The results single out
the adaptor protein Nck as a candidate cellular protein for SH3
domain-dependent binding of R-Ras and show that the
integrity of SH3 domain binding is necessary for the ability of R-Ras
to regulate integrin-mediated cell attachment.
The interactions of the R-Ras proline-rich domain have the hallmarks of
an SH3 domain interaction. Three lines of evidence: direct binding
assays with fusion proteins, two-hybrid analysis, and
coimmunoprecipitation from cells, demonstrate the specificity and high
avidity of the R-Ras binding to an SH3 domain of Nck. Nck is an adaptor
protein comprising three consecutive SH3 domains and a C-terminal SH2
domain (41). Our use of SH3 domain fusion proteins in the binding
assays places the interaction site in Nck to the SH3 domains,
specifically to the middle SH3 domain. Moreover, our mutational
analysis showed that the proline-rich segment of R-Ras, which includes
three adjacent copies of the SH3 domain-binding consensus sequence
PXXP, is the binding site on the R-Ras side. To our
knowledge, this is the first demonstration of an SH3 domain interaction
by a small GTPase. The independence of the SH3 domain binding on the
GTP/GDP regulation of R-Ras suggests that Nck (and other SH3 domain
proteins that might bind to this site) functions as an adaptor, rather
than as downstream effector, of R-Ras.
The Nck SH3 domain fragment was the only efficient binder of the R-Ras
C-terminal proline-rich sequence; fusion proteins of SH3 domains from
nine other proteins showed no significant binding. The specificity of
the SH3 domain binding was further underscored by the fact that only
one of the three SH3 domains of Nck bound the R-Ras fragment. Moreover,
we were also able to show that the Nck-R-Ras interaction takes place in
cells. Specific binding of these proteins was seen in yeast two-hybrid
tests, and we were also able to co-immunoprecipitate R-Ras and Nck from
human cell extracts. The co-immunoprecipitation of Nck and R-Ras was
only seen after transfection of the two proteins into the test cells, and only a small fraction of the transfected R-Ras appeared to be
associated with Nck. This is not surprising, given the many other
interactions of Nck with cellular signaling proteins. The interaction
may also be regulated in such a way that only a subfraction of R-Ras is
bound to Nck at any given time. Although we cannot exclude the
possibility that some other SH3 domain proteins might also interact
with R-Ras, these results suggest that R-Ras may be a physiological
ligand of Nck.
The SH3 domain-binding site of R-Ras identified in this study may serve
to target R-Ras to appropriate subcellular locations. The site is
located in the 20 amino acids preceding the conserved C-terminal
tetrapeptide motif, the CAAX box. This stretch of amino acids is highly variable among the various Ras proteins (42). However,
it is conserved in the same Ras protein among species. The C-terminal
regions of the only two R-Ras proteins for which the sequences are
available, human and mouse, differ by one amino acid, and the
proline-rich sequences are identical. This conservation suggests that
the C-terminal region plays an important role in defining the divergent
functions of the individual Ras proteins. In R-Ras, one such function
appears to be SH3 domain binding.
Nck, a candidate binder of R-Ras in cells, interacts through its SH2
domain with p130Cas (43) and with activated receptor
protein tyrosine kinases (44), including Eph receptors (45).
p130Cas is a docking protein that accumulates in focal
adhesions, which also contain clustered integrins (46, 47). Nck also
associates with the focal adhesion kinase (48). Many tyrosine kinase
receptors, including the insulin, platelet-derived growth factor and
vascular endothelial growth factor receptors are also associated with
integrins (49). Thus, Nck could, by binding to these molecules through an SH2 domain interaction and to R-Ras through an SH3 domain, bring
R-Ras close to integrins. In addition, Nck may be able to bind R-Ras
with its middle SH3 domain while simultaneously binding another protein
with its other two SH3 domains. The cytoskeleton-associated proteins
WASP and dynamin are possible candidates for such binding, because they
interact with a different Nck SH3 domain (the C-terminal one) than
R-Ras (50). How such interactions might contribute to cell adhesion
regulation by R-Ras remains to be determined.
We thank Dr. B. Mayer for pEBB-Nck construct,
Dr. J.-L. Guan for anti-HA antibody, Dr. M. Sakaue for the
GSC-NcK-S43(2) construct, and Drs. Eva Engvall and Kristiina Vuori for
comments on the manuscript.
*
This work was supported by Grants CA 67224 and the Cancer
Center Support Grant CA30199 from the National Cancer Institute.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Div. of Pathology, Karolinska Inst., Stockholm, Sweden.
¶
To whom correspondence should be addressed: Cancer Research
Center, Burnham Inst., 10901 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 619-646-3125; Fax: 619-646-3198; E-mail: ruoslahti@ burnham.org.
The abbreviations used are:
HA, hemagglutinin;
MBP, maltose-binding protein;
GST, glutathione
S-transferase;
PBS, phosphate-buffered saline;
BSA, bovine
serum albumin;
PAGE, polyacrylamide gel electrophoresis;
GTP
R-Ras Contains a Proline-rich Site That Binds to SH3 Domains
and Is Required for Integrin Activation by R-Ras*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
IIb
3 integrin in blood clotting and the
activation of the leukocyte
2 integrins in inflammation
(1, 2).
2 integrin subunit and can up-regulate the activity of
2 integrins in leukocytic cells (8). Endonexin is a
3-binding protein that increases the activity of the
IIb
3 integrin when overexpressed in cells
(9). ILK is a protein kinase capable of interacting with
1,
2, and
3 integrin
subunit cytoplasmic tails; it can reduce the activity of integrins
containing these subunits (10). The
calcium/calmodulin-dependent protein kinase II also
down-regulates integrin activity (11).
1 integrin cytoplasmic domain, and this phosphorylation reduces the ligand binding activity of
1 integrins and
changes their subcellular localization (12, 13). The small GTPases of
the Ras and Rho families are intimately involved in integrin and
cytoskeletal regulation. The activation of Rho induces reorganization of the actin cytoskeleton, with consequent cell spreading and effects
on integrins (14, 15). The related proteins Rac and Cdc42 alter the
cytoskeleton differently than Rho, inducing membrane ruffling and
microspike formation, respectively. The oncogenic p21ras (Ras)
reduces integrin activity (16).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(24), Abl
(25), Grb2 (C), Fgr, spectrin, and phospholipase C
(26) have been
described. Nck deletion mutants were constructed by removing SH3 domain
individually from the C terminus of NcK by polymerase chain reaction
(27). The polymerase chain reaction fragments were then cloned into
PGEX-4T1 and expressed as GST fusion proteins. The plasmid for GST
fusion protein of the second SH3 domain was obtained from Dr. Sakaue.
Expression vectors for GST-R-Ras and GST-R-Ras-(P202A,P203A) were
constructed by digesting the plasmids pcDNA3-Myc-R-Ras and
pMRR-(P202A,P203A) with EcoRI and XhoI. The
released inserts were then cloned into the vector PGEX4T1 (Amersham
Pharmacia Biotech). All of the fusion proteins were expressed in
bacteria and purified on glutathione-Sepharose (Amersham Pharmacia
Biotech) as described (28).
S
or 1 mM GDP in 200 µl of the loading buffer for 15 min at
37 °C. After the incubation, MgCl2 was added to a final
concentration of 10 mM to stabilize the binding, 1 ml of
cell lysate from 293 cells expressing HA-Nck (full length) was then
added to GST-R-Ras beads loaded with GTP
S or GDP. After incubation
at 4 °C for 1 h, the beads were washed three times with wash
buffer (20 mM Tris-HCl, 130 mM NaCl, 1 mM EDTA, 4 mM MgCl2, 0.1% Nonidet
P-40, 10% glycerol, 1 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride) and resuspended in
SDS-PAGE sample buffer. After electrophoresis, proteins were
transferred to the polyvinylidene difluoride membrane and blotted with
anti-HA antibody to visualize HA-Nck.
-D-galactoside in 60 mM Na2HPO4, 10 mM KCl,
1 mM MgCl2, pH 7.0, at 30 °C.
-32P]GTP in 50 µl of binding buffer (20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM MgCl2, 5 mM EDTA, 0.1% BSA,
10% glycerol, and 1 mM dithiothreitol) for 30 min at room
temperature. Glutathione-Sepharose and 500 µl of ice-cold wash buffer
(20 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 20 mM MgCl2) were added, and the mixture was
incubated for 1 h at 4 °C. The beads were washed three times
with the washing buffer and eluted with 100 µl of elution buffer (1%
SDS and 20 mM EDTA) for 5 min at 65 °C. Radioactivity of
a 20-µl sample was quantified by scintillation counting.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
Proline-rich R-Ras sequence.
A, the putative SH3 domain-binding site for Nck at residues
199-206 of R-Ras. Indicated are three possible PXXP motifs.
The third motif conforms to the consensus sequence for type II
SH3-binding sites. B, Ha-Ras does not have any polyproline
sites. Only two other members of the Ras superfamily small GTPases
(TC21 and CDC42Hs) contain a PXXP motif.

View larger version (25K):
[in a new window]
Fig. 2.
Binding of SH3 domains to R-Ras proline-rich
site. A and B, the C-terminal region of
R-Ras containing the proline-rich sequence (residues 119-212) was
fused to MBP in pPR997 vector. This fusion protein (MBP-RRC) and its
proline to alanine mutant derivatives (P202A, P203A, and double mutant
P202A,P203A) were labeled with 125I, and equal amounts of
each protein were tested for binding to SH3 domains from various
proteins, produced as GST fusion proteins in bacteria, and immobilized
on glutathione-Sepharose. Bound materials were eluted with SDS-PAGE
sample loading buffer and separated on a 4-20% gradient gel.
A, MBP-RRC but not MBP binds strongly to Nck. B,
the proline to alanine R-Ras mutants show reduced binding to the Nck
SH3 domain fragment. C, R-Ras interacts with the second SH3
domain of Nck. The full-length of GST-Nck fusion protein and GST fusion
proteins of Nck mutants in which the second or third SH3 domain had
been deleted, as well as a GST fusion protein of the second SH3 domain,
were immobilized on glutathione-Sepharose beads. The beads were
incubated with equal amounts of cell lysates from Myc-Ras transfected
293T cells at 4 °C for 1 h. After washing, the bound proteins
(including the GST fusion protein) were eluted with SDS-PAGE sample
buffer and blotted with anti-R-Ras antibody (Santa Cruz Biotechnology).
Protein staining (lower panel) shows that equal amounts of
the fusion proteins had bound to the beads. D, both GTP and
GDP forms of R-Ras bind Nck. GST-R-Ras immobilized on
glutathione-Sepharose beads was preloaded with GTP
s or GDP
s. The
beads were incubated with lysates prepared from cells expressing
HA-Nck. Bound proteins were eluted with SDS-PAGE sample buffer,
separated on a 4-20% gradient gel and transferred to a polyvinylidene
difluoride membrane. Immunoblotting of the membrane with anti-HA showed
Nck binding to GST-R-Ras loaded with either GTP or GDP but not to
GST.
) was the "bait." R-Ras and Nck
interacted strongly in this growth assay (Fig.
3) as well as in an assay based on
-galactosidase activity (not shown). As expected (40), R-Ras
interacted also with Raf-1 (not shown). A negative control using lamin
as bait showed no signal with the Nck prey. Thus, the SH3 domain is
active in yeast cells, and R-Ras can associate specifically with Nck in
these cells.

View larger version (85K):
[in a new window]
Fig. 3.
Yeast two-hybrid test of R-Ras binding to
Nck. Colonies obtained by cotransformation of the yeast with
BTM116-R-Ras-CAAX
or BTM116-lamin
and VP16-Nck were grown in histidine-containing medium for 2 days at
30 °C and then streaked onto His+ and His
plates. The plate was photographed after 5 days of growth.

View larger version (35K):
[in a new window]
Fig. 4.
In vivo association between Nck
and R-Ras and its reduction by mutation of the proline-rich site of
R-Ras. A, COS7 cells were cotransfected with expression
vectors for Nck and HA-tagged R-Ras or R-Ras-(P202A,P203A) mutant
(left two lanes). Right lanes show cells
transfected with HA-tagged Nck together with Myc-tagged R-Ras or
Ras-(P202A,P203A) mutant. Immunoblots were performed on whole cell
lysates to demonstrate similar levels of expression of wild type and
mutant R-Ras. B, about 200 mg of cell lysates were used for
immunoprecipitation of Nck with anti-Nck for Nck-transfected cells or
with anti-HA for HA-Nck-transfected cells. The associated R-Ras was
detected with an anti-HA or anti-Myc antibody.

View larger version (39K):
[in a new window]
Fig. 5.
Suppression of the cell attachment promoting
activity of R-Ras by SH3 domain-binding site mutation.
Mouse monocytic 32D cells were stably transfected with various
HA-tagged R-Ras constructs (wild type, 38V, 38V-(P202A,P203A)) or
vector (pcDNA3) alone. The morphology of G418-resistant cells after
3 weeks of selection in culture is shown for cells transfected with
R-Ras38V (A), R-Ras38V-(P202A,P203A) mutant (B),
and vector alone (C). D, two clonal cell lines
were established from each of the transfections with R-Ras38V (C3 and
C23) and the R-Ras proline double mutant ((P202A,P203A)-C1 and
(P202A,P203A)-C2). These cells, and cells transfected with wt R-Ras
(wt) or vector alone (vector), were tested for
adhesion to microtiter wells coated at various concentrations of
fibronectin (FN). A representative experiment from three is
shown. The results represent average from duplicate wells with standard
deviation less than 10% of the indicated values.

View larger version (45K):
[in a new window]
Fig. 6.
Binding of GTP by R-Ras-(P202A,P203A)
mutant. Purified GST-R-Ras, GST-R-Ras-(P202A,P203A), and GST were
incubated with [
-32P]GTP. The fusion proteins were
isolated on glutathione-Sepharose, and bound [
-32P]GTP
was eluted and quantitated by scintillation counting. The experiments
were done in triplicate. The figure shows the means ± standard
deviation.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Present address: MetroHealth Medical Center, R421, Case Western
Reserve University School of Medicine, Cleveland, OH.
![]()
ABBREVIATIONS
S, guanosine 5'-3-O-(thio)triphosphate.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Haas, T. A.,
and Plow, E. F.
(1994)
Curr. Opin. Cell Biol.
6,
656-662[CrossRef][Medline]
[Order article via Infotrieve]
2.
Springer, T. A.
(1994)
Cell
76,
301-314[CrossRef][Medline]
[Order article via Infotrieve]
3.
Hynes, R. O.
(1992)
Cell
69,
11-25[CrossRef][Medline]
[Order article via Infotrieve]
4.
Schwartz, M. A.,
Schaller, M. D.,
and Ginsberg, M. H.
(1999)
Annu. Rev. Cell Dev. Biol.
11,
549-499[CrossRef][Medline]
[Order article via Infotrieve]
5.
Kucik, D. F.,
Dustin, M. L.,
Miller, J. M.,
and Brown, E. J.
(1996)
J. Clin. Invest.
97,
2139-2144[Medline]
[Order article via Infotrieve]
6.
Yauch, R. L.,
Felsenfeld, D. P.,
Kraeft, S.-K.,
Chen, L. B.,
Sheetz, M. P.,
and Hemler, M. E.
(1997)
J. Exp. Med.
186,
1347-1355 7.
Burridge, K.,
and Chrzanowska-Wodnicka, M.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
463-518[CrossRef][Medline]
[Order article via Infotrieve]
8.
Kolanus, W.,
Nagel, W.,
Schiller, B.,
Zeitlmann, L.,
Godar, S.,
Stockinger, H.,
and Seed, B.
(1996)
Cell
86,
233-242[CrossRef][Medline]
[Order article via Infotrieve]
9.
Kashiwagi, H.,
Schwartz, M. A.,
Eigenthaler, M.,
Davis, K. A.,
Ginsberg, M. H.,
and Shattil, S. J.
(1997)
J. Cell Biol.
137,
1433-1443 10.
Dedhar, S.,
and Hannigan, G. E.
(1996)
Curr. Opin. Cell Biol.
8,
657-669[CrossRef][Medline]
[Order article via Infotrieve]
11.
Bouvard, D.,
Molla, A.,
and Block, M. R.
(1998)
J. Cell Sci.
111,
657-665[Abstract]
12.
Hirst, R.,
Horwitz, A.,
Buck, C.,
and Rohrschneider, L.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
6470-6474 13.
Johansson, M.,
Larsson, E,
Lüning, B.,
Pasquale, E. B.,
and Ruoslahti, E.
(1994)
J. Cell Biol.
126,
1299-1309 14.
Hotchin, N. A.,
and Hall, A.
(1995)
J. Cell Biol.
131,
1857-1865 15.
Machesky, L. M.,
and Hall, A.
(1997)
J. Cell Biol.
138,
913-926 16.
Hughes, P. E.,
Renshaw, M. W.,
Pfaff, M.,
Forsyth, J.,
Keivens, V. M.,
Schwartz, M. A.,
and Ginsberg, M. H.
(1997)
Cell
88,
521-530[CrossRef][Medline]
[Order article via Infotrieve]
17.
Zhang, Z.,
Vuori, K.,
Wang, H.,
Reed, J. C.,
and Ruoslahti, E.
(1996)
Cell
85,
61-69[CrossRef][Medline]
[Order article via Infotrieve]
18.
Ramos, J. W.,
Hughes, P. E.,
Fenczik, C. A.,
and Ginsberg, M. H.
(1998)
J. Biol. Chem.
273,
33897-33900 19.
Keely, P. J.,
Rusyn, E. V.,
Cox, A. D.,
and Parise, L. V.
(1999)
J. Cell Biol.
145,
1077-1088 20.
Huff, S. Y.,
Quilliam, L. A.,
Cox, A. D.,
and Der, C. J.
(1997)
Oncogene
14,
133-143[CrossRef][Medline]
[Order article via Infotrieve]
21.
Wang, H. G.,
Millan, J. A.,
Cox, A. D.,
Der, C. J.,
Rapp, U. R.,
Beck, T.,
Zha, H.,
and Reed, J. C.
(1995)
J. Cell Biol.
129,
1103-1114 22.
Tanaka, M.,
Gupta, R.,
and Mayer, B. J.
(1995)
Mol. Cell Biol.
15,
6829-6837[Abstract]
23.
Taylor, S. J.,
Anafi, M.,
Pawson, T.,
and Shalloway, D.
(1995)
J. Biol. Chem.
270,
10120-10124 24.
Liu, X.,
Marengere, L. E.,
Koch, C. A.,
and Pawson, T.
(1993)
Mol. Cell Biol.
13,
5225-5232 25.
Cicchetti, P.,
Mayer, B. J.,
Thiel, G.,
and Baltimore, D.
(1992)
Science
257,
803-806 26.
Gout, I.,
Dhand, R.,
Hiles, I. D.,
Fry, M. J.,
Panayotou, G.,
Das, P.,
Truong, O.,
Totty, N. F.,
Hsuan, J.,
Booker, G. W.,
et al..
(1993)
Cell
75,
25-36[CrossRef][Medline]
[Order article via Infotrieve]
27.
Kitamura, Y.,
Kitamura, T.,
Sakaue, H.,
Maeda, T.,
Ueno, H.,
Nishio, S.,
Ohno, S.,
Osada, S.,
Sakaue, M.,
Ogawa, W.,
and Kasuga, M.
(1997)
Biochem. J.
322,
873-878
28.
Guan, K.,
and Dixon, J. E.
(1991)
Anal. Biochem.
192,
262-267[CrossRef][Medline]
[Order article via Infotrieve]
29.
Wang, B.,
Dickinson, L. A.,
Koivunen, E.,
Ruoslahti, E.,
and Kohwi- Shigematsu, T.
(1995)
J. Biol. Chem.
270,
23239-23242 30.
Morla, A.,
and Ruoslahti, E.
(1992)
J. Cell Biol.
118,
421-429 31.
Vojtek, A. B.,
Hollenberg, S. M.,
and Cooper, J. A.
(1993)
Cell
74,
205-214[CrossRef][Medline]
[Order article via Infotrieve]
32.
Vojtek, A. B.,
and Hollenberg, S. M.
(1995)
Methods Enzymol.
255,
331-342[Medline]
[Order article via Infotrieve]
33.
Schiestl, R. H.,
and Gietz, R. D.
(1989)
Curr. Genet.
16,
339-346[CrossRef][Medline]
[Order article via Infotrieve]
34.
Alexandropoulos, K.,
Cheng, G.,
and Baltimore, D.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
3110-3114 35.
Sparks, A. B.,
Rider, J. E.,
Hoffman, N. G.,
Fowlkes, D. M.,
Quilliam, L. A.,
and Kay, B. K.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1540-1544 36.
Drivas, G. T.,
Shih, A.,
Coutavas, E.,
Rush, M. G.,
and D'Eustachio, P.
(1990)
Molec. Cell Biol.
10,
1793-1798 37.
Shinjo, K.,
Koland, J. G.,
Hart, M. J.,
Narasimhan, V.,
Johnson, D. I.,
Evans, T.,
and Cerione, R. A.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
9853-9857 38.
Munemitsu, S.,
Innis, M. A.,
Clark, R.,
McCormick, F.,
Ullrich, A.,
and Polakis, P.
(1990)
Mol. Cell Biol.
10,
5977-5982 39.
Soans, C.,
Holash, J. A.,
Pavlova, Y.,
and Pasquale, E. B.
(1996)
J. Cell Biol.
135,
781-795 40.
Winning, R. S.,
Scales, J. B.,
and Sargent, T. D.
(1996)
Dev. Biol.
179,
309-319[CrossRef][Medline]
[Order article via Infotrieve]
41.
Spaargaren, M.,
Martin, G. A.,
McCormick, F.,
Fernandez-Sarabia, M. J.,
and Bischoff, J. R.
(1994)
Biochem. J.
300,
303-307
42.
Lehmann, J. M.,
Riethmuller, G.,
and Johnson, J. P.
(1990)
Nucleic Acids Res.
18,
1048 43.
Barbacid, M.
(1987)
Annu. Rev. Biochem.
56,
779-827[CrossRef][Medline]
[Order article via Infotrieve]
44.
Schlaepfer, D. D.,
Broome, M. A.,
and Hunter, T.
(1997)
Mol. Cell Biol.
17,
1702-1713[Abstract]
45.
Li, W.,
Hu, P.,
Skolnik, E. Y.,
Ullrich, A.,
and Schlessinger, J.
(1992)
Mol. Cell Biol.
12,
5824-5833 46.
Holland, S. J.,
Peles, E.,
Pawson, T.,
and Schlessinger, J.
(1998)
Curr. Opin. Neurobiol.
8,
117-127[CrossRef][Medline]
[Order article via Infotrieve]
47.
Hanks, S. K.,
and Polte, T. R.
(1996)
BioEssays
19,
137-145
48.
Choudhury, G. G.,
Marra, F.,
and Abboud, H. E.
(1996)
Am. J. Physiol.
270,
F295-F300 49.
Giancotti, F. G.,
and Ruoslahti, E.
(1999)
Science
285,
1028-1032 50.
McCarthy, J. H.
(1998)
BioEssays
20,
913-921[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Lehto, M. I. Mayranpaa, T. Pellinen, P. Ihalmo, S. Lehtonen, P. T. Kovanen, P.-H. Groop, J. Ivaska, and V. M. Olkkonen The R-Ras interaction partner ORP3 regulates cell adhesion J. Cell Sci., March 1, 2008; 121(5): 695 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, Y. Hao, and L. A. Feig The R-Ras GTPase Mediates Cross Talk between Estrogen and Insulin Signaling in Breast Cancer Cells. Mol. Cell. Biol., September 1, 2006; 26(17): 6372 - 6380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. ten Klooster, Z. M. Jaffer, J. Chernoff, and P. L. Hordijk Targeting and activation of Rac1 are mediated by the exchange factor {beta}-Pix J. Cell Biol., February 27, 2006; 172(5): 759 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Holly, M. K. Larson, and L. V. Parise The Unique N-Terminus of R-Ras Is Required for Rac Activation and Precise Regulation of Cell Migration Mol. Biol. Cell, May 1, 2005; 16(5): 2458 - 2469. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Jeong, J.-O. Nam, and I.-S. Kim The COOH-terminal End of R-Ras Alters the Motility and Morphology of Breast Epithelial Cells through Rho/Rho-Kinase Cancer Res., January 15, 2005; 65(2): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Furuhjelm and J. Peranen The C-terminal end of R-Ras contains a focal adhesion targeting signal J. Cell Sci., September 15, 2003; 116(18): 3729 - 3738. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Endo, M. Shirouzu, and S. Yokoyama The Cdc42 Binding and Scaffolding Activities of the Fission Yeast Adaptor Protein Scd2 J. Biol. Chem., January 3, 2003; 278(2): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Han, T.-L. Shen, H. Miao, B. Wang, and J.-L. Guan EphB1 Associates with Grb7 and Regulates Cell Migration J. Biol. Chem., November 15, 2002; 277(47): 45655 - 45661. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-F. Lee, J. Guan, Y. Qiu, and H.-J. Kung Neuropeptide-Induced Androgen Independence in Prostate Cancer Cells: Roles of Nonreceptor Tyrosine Kinases Etk/Bmx, Src, and Focal Adhesion Kinase Mol. Cell. Biol., December 15, 2001; 21(24): 8385 - 8397. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tian and L. A. Feig Basis for Signaling Specificity Difference between Sos and Ras-GRF Guanine Nucleotide Exchange Factors J. Biol. Chem., December 7, 2001; 276(50): 47248 - 47256. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||